CLSDQ — Clearside Biomedical, Share News
0.000.00%
Last trade - 00:00- $1.31m
- $55.68m
- $1.66m
Clearside Biomedical Inc reports results for the quarter ended in June - Earnings Summary
Brief: Clearside Biomedical Inc - Clearside Biomedical Enters Into Non-Dilutive Financing Agreement With Healthcare Royalty Partners For Up To $65 Million
Brief: Clearside Biomedical Completes Dosing In Oasis Phase 1/2A Clinical Trial Of CLS-AX In Wet AMD Patients
Clearside Biomedical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Clearside Biomedical Announces First Quarter 2022 Financial Results
Clearside Biomedical Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Verastem, Nio, metal miners
U.S. STOCKS ON THE MOVE-DatChat Inc, HP Inc, Natural gas firms
Clearside Biomedical rises on U.S. launch of eye therapy
Brief: Bausch + Lomb And Clearside Biomedical Announce The U.S. Commercial Launch Of Xipere
U.S. STOCKS ON THE MOVE-Discovery, Illumina, Comtech Telecommunications
U.S. STOCKS ON THE MOVE-WeWork, Oracle Corp, Boeing Co
U.S. STOCKS ON THE MOVE-Docusign, Chevron Corp, Lazydays Holdings
U.S. STOCKS ON THE MOVE-DiDi, Rivian, Tilly's Inc
Clearside Biomedical gains on Q4 profit
Brief: Clearside Biomedical Announces Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update
Clearside Biomedical Inc reports results for the quarter ended in December - Earnings Summary
Clearside Biomedical Inc expected to post earnings of 16 cents a share - Earnings Preview
Brief: Clearside Biomedical’S Suprachoroidal Injection Platform Featured At The Angiogenesis, Exudation, And Degeneration 2022 Virtual Conference